The contribution of TCF19 to tumor progression by controlling cellular proliferation has been reported in gastric cancer [14], hepatocellular carcinoma [15, 19], non‐small cell lung cancer [17, 20], colorectal cancer [13], and liver cancer [18]. This evidence concerns the gene TCF19 and neoplasm.